chrisvoncsefalvay/vaers-outcomes huggingface dataset:
stroke; hemoglobin won't stay above 7; anemia; muscle atrophy; persistent fevers; inflammation; infectious disease; white blood cells are low; This is a spontaneous report from a contactable consumer. This consumer reported similar events for three patients. This is the third of three reports which corresponds to the second person the reporter knew who experienced the same events as her father.   A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not provided), via an unspecified route of administration on an unspecified date at dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer was reporting for her father and mentioned that she personally knew two people who had the same situation in the blood as her father. It was reported that the patient experienced stroke, hemoglobin won't stay above 7, anemia, muscle atrophy, persistent fevers with signs of inflammation and infectious disease, and low white blood cells. The patient had been in the hospital for three months (90 days). Therapeutic measures were taken as a result of the events. The consumer mentioned that Pfizer has reached out to them and gave them some sort of medicine that helped regulate the blood. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021751102 same reporter and drug, similar events, different patients;US-PFIZER INC-2021748630 same reporter and drug, similar events, different patients
pt recv vax & devel a 2.5inch by 5 inch area of redness & warmth @ site of vax;A 40mm papule formed @ the inj site;pt recovered;this is 1 of 4 pt from this site to have an adverse exp p/vax;
Influenza vaccine given evening of 10/13/2010 in left arm.  On 10/15/2010 early am client noticed hives and itching on neck, arms, chest, upper back, head, ears.  No chest tightness, no throat tightness, not shortness of breath.  Explained to client that she should call her physician. She was not sure if any of the rash started on 10/14/2010.
Pt rec'd varicella vaccine 7/10/02. Broke out with chicken pox 5/4/03. 5/5/03 treated with Zovirax qid x 5d.
Developed shingles for first time soon after second vaccine. Dermatologist sent scraping from blister to lab and lab confirmed.
1100 Pt reports increased in nausea and "feels like is going to throw up".  Pale and diaphoretic.  Pt reports name and states has hx of vagal with injections/vaccinations and sutures-which occurred 2 years ago.  EMS activated. Pt increase with diaphoretic and vomited x 2.  EMS assessed and controlled situation. Pt appeared to recover without difficulty after 10-15 minutes.  Drank 16.9 oz.  bottle water. Ambulated  independently without asst to exit.  Pt reports he is not driving and he has a ride. Pt instructed to inform medical to lay down prior to 2nd/next injection/vaccination in 3 weeks. Pt verbalized understanding.
Pt called for assistance, stated feeling warm and felt faint. Pt asked for water. Face flushed, neck and upper chest slight redness. slef ambulated to medical tent. Pt was d/c by physician after feeling better
lightheaded, seen & cleared by EMS; B/P 150/90, P- 96
she had a couple spots on the back of her thigh; her ears are swollen red and itchy; there is a heat to the rash; she started getting a hot, red, swollen, itchy rash on the palm of her hands; itchy rash/her ears are swollen red and itchy/the other hand is still red swollen and itchy; she had a rash in one palm of the hand and the next day had it on the other hand and then her knee, ear/it has worsened because it is in a lot more areas now; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EP6955; Expiration Date: 30Jun2021), via an unspecified route of administration on 22Mar2021 (at the age of 41 year old) as dose 1, single for COVID-19 immunisation. Medical history and concomitant medications were reported as none. On 22Mar2021, she got the first dose of the vaccine. On 24Mar2021, she started getting a hot, red, swollen, itchy rash on the palm of one hand, then next day (25Mar2021), found on other hand, then it spread to one of her knees, she had a couple spots on the back of her thigh, also her ears were swollen red and itchy. She has been to the urgent care, dermatologist, and pharmacy, where they told her to call Pfizer. Patient confirmed that she has not been in contact with anything, has been staying in home, has not had any new soaps or doesn't had anything that were linking the reaction to the vaccine. The biggest thing she worries about is getting the second dose. She was asking, should she get the second dose and it had been a week and a half since she got the first vaccination. At the time of report, the first side it started on, where her left had not started, so the initial side it started on is much better but that took a week. Patient would say rash has worsened, because it is in a lot more areas at the time of report.  Her both ears were red, swollen and itchy and the other hand is still red swollen and itchy and there is a heat to the rash. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/13/2021 and 2/10/2021. Presented to ED on 8/31/2021 for weakness secondary to hyponatremia which is acute on chronic.  She was incidentally found to have COVID-19 infection.She was treated with stress dose Solu-Cortef.  During her 1st 24 hour, she started to show some desaturation.  She was started on dexamethasone 6 mg daily.  Patient continue showing no respiratory symptoms.  Her hypoxia did worsen slightly during her hospital stay and the maximum need of oxygen was 3-4 L.  Her examination showed no wheezes or rales.  And she has no respiratory symptoms. Patient was discharged on 9/4/2021. On 9/7/2021 presented to the ED with mild hypoxemia and shortness of breath. She was started on dexamethasone therapy and broad-spectrum empiric antibiotics with cefepime.  She received baricitinib from 9/8-12 but discontinued for suspected thrombosis. She continued to require increasing oxygen and ultimately on 09/17 intubated.  Blood culture and sputum culture have been negative respiratory pneumonia panel was negative, MRSA nasal swab negative.  She has been receiving Unasyn for possible aspiration pneumonia. Unfortunately, she continued to progressively worsen developing renal failure with multi-system organ failure, acidosis, hyperkalemia, and refractory shock on multiple pressors. On 9/21 patient's family elected for comfort care. Patient expired 9/21/2021.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment was reported. No concomitant medication was reported.
Severe swelling of left arm, pain, unable to bend, sleep, redness, swelling, itchy on whole arm
Breakthrough case admission after three vaccines  Moderna 3/2/21 Lot# 030A21A;  Moderna 4/1/21 Lot# 006B21A;  Moderna 12/2/21 Lot# 034F21A
Information has been received from a registered nurse referring to a patient of unknown age and gender. Patient's current conditions, medical history and concomitant medications was not provided. On 12-AUG-2015, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (lot # K021935, expiration date 10-NOV-2016, dose and route were unknown) that was improperly stored. It was reported that the doses were administered following an excursion of 14F from 28-AUG-2015 to 17-NOV-2015. No adverse effects was reported. This is one of several reports received from the same source. Additional information has been requested.
She had pain initially after administration & soreness a few days afterward, but about 6-7 days post dose pain got much worse, extremely painful at injection site and a lump became swollen & hot where injection was given. Extremely painful.
12-31-20: arm sore in shot area. Ibuprofen  1-1-21: stiff arm and can?t raise above shoulder, arm pain. Ibuprofen  1-2-21: Hives start on both elbows and both sides of body.  Larger welts (photo). Itchy.  6am starts.   1-3-21: Same as above but hives getting smaller and itchy less. 1-3-21:  lost appetite.  Took zinc for next 2days.  1-4-21: lost appetite.    M
Maculopapular rash on chest, abd, back seen in clinic on 12/17/2009.
No adverse events were reported. This form is being completed because it was brought to my attention the patient received her second vaccination 2 weeks after her first dose rather than 3 weeks as approved under the EUA.
Lymphnodes swollen under right arm; throat swollen; trouble breathing especially at night; This is a spontaneous report received from a contactable consumer (Patient). A 51-year-old non-pregnant female patient received bnt162b2 (BNT162B2; Solution for injection; Lot number: Unknown), via an unspecified route of administration, administered in right arm as dose number unknown, single on 27Apr2021 at 09:00 (at the age of 51-year-old) for covid-19 immunisation at doctor's office/urgent care. Patient had no known allergies and had been diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not been tested for Covid 19 since the vaccination. The patient's concomitant medications were not reported. On 28Apr2021 at 21:00, the patient experienced lymph nodes swollen under right arm, throat swollen and trouble breathing especially at night. No treatment was received as result of adverse events. Device Date was 01May2021. At the time of this report, the outcome of events was not recovered.  No follow up attempts are needed. Information about lot/batch number cannot be obtained.
pt recv 2 doses of vax AUG95 & SEP95 & MAY96 lab eval revealed a lack of titer;
sweats; sore throat; headache; nausea; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003BB21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HYPERHIDROSIS (sweats), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, HYPERHIDROSIS (sweats), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Recieved Zostavax on 09/15/2008.Twenty-four hours later, developed fever, joint and body aches, swelling, pain and redness from shoulder to elbow.  The next day, fever was 99.7 oral.  Patiesnt developed a headache.  Still has a little headache one week later, but otherwise back to normal.
chest pain; heart burn; chills; fever; body pains; terrible headache; tired; weak.; I had shortness of breath; This is a spontaneous report from a contactable consumer(patient). A 47-year-old non pregnant female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date unknown) on 21Jan2021 at 04:00 PM via an unspecified route of administration in left arm at single dose for covid-19 immunization. Patient was 47 years old at the time of vaccination. Patient medical history and concomitant medications were not reported. Patient did not have any known allergies. Patient did not receive any other medications in two weeks. Patient did not receive any other vaccine in four weeks. Patient did not have covid prior vaccination. On 21Jan2021 at 8PM patient had shortness of breath, chest pain, heart burn, chills, fever, body pains, terrible headache, tired, and weak. It lasted until 10AM the next day. Effects lasted for 12 hours. On 06Jan2021 patient tested for covid post vaccination with test name Saliva and result received was negative. The outcome of the events was recovered.   Information on the lot/batch number has been requested.
Patient developed acute liver injury with transminitis to 900ss ALT, 1000s AST, TBili low 20s at peak. This was thought to be secondary to autoimmune hepatitis based upon initial biopsy results. This began within 2 weeks of vaccination based on history, although patient is not exactly sure when his initial symptoms were.
Patient called pharmacy 04/28/21 in the morning stating that she was having a reaction from the Moderna  vaccine given 4/23/21.  She stated that on Sunday 4/25/21, she began developing a raised, itchy rash.  The symptoms have not subsided.  The rash began on the arm vaccine was given and has now spread over body.  She had not taken Benadryl the last couple of days.  She was instructed to take 1 or 2 capsules of 25mg diphenhydramine every four to six hours to see if that alleviated the itchiness.  If the rash continued to spread, she was instructed to call her physician to be seen.
Stabbing pain in the lower thoracic region going through to near the bottom of the sternum.  Went to the emergency room because it was the weekend and was diagnosed by the doctor as a muscle spasm.  Muscle relaxants had no effect and less than 24 hours later a rash appeared. Sent an image to my GP who said it was shingles.  Was prescribed the antivirus and Gabapentin.  The rash went away quickly.  The pain last 10-12 weeks.  Now, over a year later I occasionally have the stabbing pain but continue to have numbness encircling by ribcage and cannot comfortably wear a bra for long.  I had nothing more than sore arm and fatigue in response to doses 2 and 3 of the Moderna Covid vaccine.  But I received my 4th dose 4/8/2, was lot 066K21A and I had a greater reaction.  Within 12 hours of the shot I had a fever of 100.1, significant joint and muscle pain and headache.  The fever lasted for 36 hours, varying up to 100.5. Continued fatigue and some dizziness for the next 24 hours.  Currently, 72 hours later, still feeling some fatigue.
About 84 hours after the vaccine was administered, I woke up in the middle of the night with my whole body tremoring and convulsions from the neck down. This lasted for a few hours then afterward my legs were extremely sore and experienced cramping and spasms. I reached out to my doctor and he said for the side effect to show this far after the shot is atypical. I will not be receiving my second dose.
some trouble breathing; just a little wheezy at first; started not feeling well; Blood pressure reading high; Heart rate increased; A spontaneous report was received from a consumer who was also a 50 years old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced some trouble breathing, started not feeling well, just a little wheezy at first, blood pressure increased and heart rate increased.  The patient's medical history included asthma and interstitial lung disease. Products known to have been used by the patient included were "oxygen tank" and "nebulizer medicines".  The patient received their first of two planned doses of mRNA-1273 (Batch number: 031L20A) on 19 Feb 2021, approximately one day prior to the onset of the symptoms intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 19 Feb 2021 about 8 minutes after the shot, patient experienced not feeling well, breathing trouble, wheezy, high blood pressure and heart rate. Patient blood pressure shot up to 210/112, heart rate was 160.  On 19 Feb 2021, patient ended up in the hospital with IV steroids and other meds, she went home on 20 Feb 2021. On 22 Feb 2021, her breathing was worse and did not feel well and she was back in the hospital. On 26 Feb 2021 patient was discharged from the hospital.  Action taken with the drug in response to the events were not reported.  The outcome of the event, some trouble breathing was considered as not recovered. The outcome of events,just a little wheezy at first and started not feeling well, blood pressure increased and heart rate increased were considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received from a registered nurse concerning a now 62 year old female with no pertinent medical history and no drug reactions or allergies who in 2006 was vaccinated with 3 doses of RECOMBIVAX HB (lot #, dose and route not reported). There was no concomitant medication. On an unspecified date, antibody titers for hepatitis B was performed and the patient had "non immune" antibody titers. The patient sought unspecified medical attention. Additional information has been requested.
Patient had just received vaccination and briefly lost consciousness. After verbal stimuli and sternal chest rub, patient resumed consciousness. He was out no longer than 10 seconds. Patient was then laid down on exam table with assistance of his mother, legs elevated. Patient advised to wait 15 minutes. At the end of this time, patient reported feeling "back to normal."
Myalgias, fever 100.5, fatigue, headaches, mild induration to left deltoid. Moderate redness and warm to touch.
Ovarian cyst two weeks after shot, I had another ovarian cyst develop within a month of my other Moderna Booster lot number 065F21a
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. It was reported that vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.
pt noted red, raised rash  at injection site,  approximately 2 inches x 2 inches. Area does not have increased warmth.
Fever 102.9; chills; symptoms developed approximately 3 hours after receiving vaccine.
Autoinnoculation from smallpox immunization - within a couple of cm's from primary site, likely secondary to bandage reaction.
Got 2nd pfizer lot # EW0150 on 03/30/2021. On 04/24/2021, had carpal tunnel release surgery. Synovial fld biopsy came back POSITIVE for amyliodosis. Have 3 different biopsy to type so far. No treatment until type amyloidosis identified. Only biopsy + is synovial fluid...other 3 biopsy abd fat, axilla lymph node negative. Awaiting results for colon biopsy.
Fever of 101F, chills, nausea (almost vomited), very painful muscle aches and pains, and every single joint in my body hurt (including top of left shoulder) lasted through the night and the next day. By 7pm the June 14th, felt better, only left shoulder pain remained. I had greatly increased pain in my left shoulder and severely decreased range of motion compared to immediately before receiving the vaccination.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date in 2016 (reported as after 29-JUL-2016), the patients received improperly stored (at 0.3 degrees Celsius for a total of five hours and five minutes) doses of ROTATEQ, lot number M014753, expiration date: 07-OCT-2017 and lot number L03853 which was not valid, expiration date: 19-AUG-2017, route of administration defaulted to oral (dose was not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Admitted to Hospital on 10/15/21 with back pain and lower extremity weakness.  Records from Hospital from a previous admission 9/29-10/4/21 were reviewed.  The following is taken from the discharge summary:  48 year old diabetic not taking any medications for at least 1 year. She reported back pain for the past 2 weeks. She did not move her right leg when asked to do so.  She complained of slurred speech for 2 days.  MRI brain did not show acute pathology.  She was found to have moderate LE weakness and had a right facila droop. She was treated with steroids and valtrex.  HA1C is 12.5  She was admitted to 10/15 with leg weakness, underwent an LP that was negative. She recieved IVIG for possible CDIP, and steroids.  Trep antibody was negative, but RPR and 2nd syphillus test serology was negative. LP no wbc and negative VDRL.  We did not think this was syphillis.
nausea; felt like head was being squeezed; tingling on leg; head feels like it is going to explode; whole body hurts; can't stand up straight; headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), HEAD DISCOMFORT (felt like head was being squeezed), PARAESTHESIA (tingling on leg), HEAD DISCOMFORT (head feels like it is going to explode) and PAIN (whole body hurts) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea), HEAD DISCOMFORT (felt like head was being squeezed), PARAESTHESIA (tingling on leg), HEAD DISCOMFORT (head feels like it is going to explode), PAIN (whole body hurts), DYSSTASIA (can't stand up straight) and HEADACHE (headache). At the time of the report, NAUSEA (nausea), HEAD DISCOMFORT (felt like head was being squeezed), PARAESTHESIA (tingling on leg), HEAD DISCOMFORT (head feels like it is going to explode), PAIN (whole body hurts), DYSSTASIA (can't stand up straight) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medication were reported.